CORT and TEVA Related Headlines
Go Back- Corcept loses patent appeal against Teva over generic Korlym
- Corcept Therapeutics stock falls after losing key patent case appeal
- Corcept Therapeutics (CORT) Drop Said Tied to Chatter it Lost Case Against Teva Pharma (TEVA)
